Literature DB >> 31702821

Immune checkpoint inhibitors may be safe for patients with preexisting autoimmune disease.

Mike Fillon.   

Abstract

Entities:  

Year:  2019        PMID： 31702821     DOI： 10.3322/caac.21587

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN： 0007-9235            Impact factor:   508.702


× No keyword cloud information.
  2 in total

1.  Hemophagocytic lymphohistiocytosis in two patients following treatment with pembrolizumab: two case reports and a literature review.

Authors:  Yanqiu Wei; Wei He; Wei Sun; Chaojie Wu; Denghua Ren; Xinmin Wang; Mingshun Zhang; Mao Huang; Ningfei Ji
Journal:  Transl Cancer Res       Date:  2022-08       Impact factor: 0.496

Review 2.  Immune Checkpoint Inhibitors in Special Populations.

Authors:  Qianyun Shan; Hongyang Lu
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.